Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1780
| Despition | DYRK1A Human Recombinant |
| SIZE | 5 µg |
| Purity | > 80% (SDS-PAGE) |
| Form | Sterile Filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1643 | Human Transthyretin Protein (AC1643) | 5 µg | inquiry |
| ACPP-1248 | Mitofusin 2 Blocking Peptide (AC1248) | 250 µg | inquiry |
| ACPP-1279 | NEDD4 Blocking Peptide (AC1279) | 250 µg | inquiry |
| ACPP-1157 | Recombinant Human GFAP Protein (6×His Tag) (AC1157) | 50 µg | inquiry |
| ACPP-1146 | Recombinant Human Artemin Protein (Fc Tag) (AC1146) | 50 µg | inquiry |
| ACPP-1004 | Synthetic Nanodisc Human GPCR GPR20 Protein (AC1004) | 10 µg | inquiry |
| ACPP-1452 | Human HSD17B1 Protein (AC1452) | 2 µg | inquiry |
| ACPP-1318 | Orexin A Blocking Peptide (AC1318) | 250 µg | inquiry |
| ACPP-1105 | Human Leptin Protein (AC1105) | 200 µg | inquiry |
| ACPP-1666 | Human LGALS3 Protein, His (AC1666) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.